Page last updated: 2024-10-31

mianserin and Hamartoma Syndrome, Multiple

mianserin has been researched along with Hamartoma Syndrome, Multiple in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Hamartoma Syndrome, Multiple: A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.

Research Excerpts

ExcerptRelevanceReference
"Steroids were restarted and his ataxia stabilized."1.46JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. ( Angeles, MR; Bucelli, RC; Clifford, DB; Dang, X; Koralnik, IJ; Kuhlmann, FM; Major, EO; Ryschkewitsch, CF; Schmidt, RE; Schwetye, KE; Soleimani-Meigooni, DN, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soleimani-Meigooni, DN1
Schwetye, KE1
Angeles, MR1
Ryschkewitsch, CF1
Major, EO1
Dang, X1
Koralnik, IJ1
Schmidt, RE1
Clifford, DB1
Kuhlmann, FM1
Bucelli, RC1

Other Studies

1 other study available for mianserin and Hamartoma Syndrome, Multiple

ArticleYear
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7.
    Journal of neurovirology, 2017, Volume: 23, Issue:1

    Topics: Aged; Ataxia; Chronic Disease; Hamartoma Syndrome, Multiple; Humans; Immunocompromised Host; Immunog

2017